Walgreens Boots Alliance, Inc. (NASDAQ:WBA)‘s stock had its “buy” rating restated by Needham & Company LLC in a research report issued on Saturday. They currently have a $94.00 price target on the pharmacy operator’s stock. Needham & Company LLC’s price target would indicate a potential upside of 13.94% from the company’s previous close.

Other analysts have also recently issued reports about the company. BidaskClub cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research report on Saturday, June 24th. Leerink Swann set a $86.00 price target on Walgreens Boots Alliance and gave the stock a “buy” rating in a research report on Friday, July 7th. Credit Suisse Group reiterated a “buy” rating and set a $97.00 price target on shares of Walgreens Boots Alliance in a research report on Thursday, July 13th. Pivotal Research set a $85.00 price target on Walgreens Boots Alliance and gave the stock a “hold” rating in a research report on Sunday, July 2nd. Finally, Goldman Sachs Group, Inc. (The) reiterated a “neutral” rating and set a $77.00 price target (down from $89.00) on shares of Walgreens Boots Alliance in a research report on Wednesday, June 28th. Two equities research analysts have rated the stock with a sell rating, three have given a hold rating and fourteen have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $91.81.

Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 82.50 on Friday. The stock has a market capitalization of $88.28 billion, a price-to-earnings ratio of 20.83 and a beta of 1.26. The firm’s 50-day moving average is $81.26 and its 200-day moving average is $81.99. Walgreens Boots Alliance has a one year low of $75.18 and a one year high of $89.69.

Walgreens Boots Alliance (NASDAQ:WBA) last announced its quarterly earnings results on Thursday, June 29th. The pharmacy operator reported $1.33 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.30 by $0.03. Walgreens Boots Alliance had a return on equity of 17.34% and a net margin of 3.69%. The company had revenue of $30.12 billion during the quarter, compared to the consensus estimate of $29.72 billion. During the same period in the previous year, the company posted $1.18 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 2.1% on a year-over-year basis. Equities research analysts forecast that Walgreens Boots Alliance will post $5.00 EPS for the current year.

Walgreens Boots Alliance declared that its board has approved a share repurchase plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to reacquire up to 5.9% of its stock through open market purchases. Stock repurchase plans are often an indication that the company’s board believes its stock is undervalued.

COPYRIGHT VIOLATION NOTICE: “Walgreens Boots Alliance’s (WBA) Buy Rating Reiterated at Needham & Company LLC” was first posted by Daily Political and is the property of of Daily Political. If you are viewing this piece of content on another domain, it was stolen and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/09/16/walgreens-boots-alliances-wba-buy-rating-reiterated-at-needham-company-llc.html.

In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction dated Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the transaction, the director now owns 19,151 shares in the company, valued at approximately $1,528,058.29. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Corporate insiders own 13.50% of the company’s stock.

A number of large investors have recently added to or reduced their stakes in WBA. Hudock Capital Group LLC grew its stake in Walgreens Boots Alliance by 0.5% during the 2nd quarter. Hudock Capital Group LLC now owns 1,306 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 6 shares during the last quarter. Westside Investment Management Inc. grew its stake in Walgreens Boots Alliance by 10.4% during the 2nd quarter. Westside Investment Management Inc. now owns 1,325 shares of the pharmacy operator’s stock worth $102,000 after buying an additional 125 shares during the last quarter. Reilly Financial Advisors LLC grew its stake in Walgreens Boots Alliance by 7.9% during the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock worth $107,000 after buying an additional 100 shares during the last quarter. Tarbox Group Inc. grew its stake in Walgreens Boots Alliance by 288.3% during the 1st quarter. Tarbox Group Inc. now owns 1,355 shares of the pharmacy operator’s stock worth $113,000 after buying an additional 1,006 shares during the last quarter. Finally, Webster Bank N. A. grew its stake in Walgreens Boots Alliance by 18.4% during the 1st quarter. Webster Bank N. A. now owns 1,509 shares of the pharmacy operator’s stock worth $125,000 after buying an additional 235 shares during the last quarter. Hedge funds and other institutional investors own 60.18% of the company’s stock.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Analyst Recommendations for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.